14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
The use of net asset value finance by private equity firms has spiked under COVID-19 as managers exp...
Read More >
New Jersey continues to become one of the country’s most employee-friendly states. On January 21, ...
Read More >
Pay equity continues to be a complex and evolving issue for employers. Although the Equal Employment...
Read More >
The NRC will soon issue in the Federal Register a proposed rulemaking to amend the drug testing requ...
Read More >
The United States Department of Justice (“DOJ”) issued a January 16th news release stating that a ...
Read More >
The National Labor Relations Board (the “NLRB”) announced yesterday that it will issue its final r...
Read More >